Plerixafor
Plerixafor | |
---|---|
Term | Plerixafor |
Short definition | plerixafor - (pronounced) (pleh-RIK-suh-for) drug used with granulocyte colony-stimulating factor before autologous stem cell transplantation in patients with non-Hodgkin's lymphoma or multiple myeloma. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
plerixafor - (pronounced) (pleh-RIK-suh-for) drug used with granulocyte colony-stimulating factor before autologous stem cell transplantation in patients with non-Hodgkin's lymphoma or multiple myeloma. It is also being studied in the treatment of other types of cancer. Plerixafor helps transport stem cells from the bone marrow into the blood so they can be collected, stored and then given back to the patient. Plerixafor is a type of hematopoietic stem cell mobilizing agent. Also called AMD 3100 and Mozobil
External links
- Medical encyclopedia article on Plerixafor
- Wikipedia's article - Plerixafor
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski